skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Simple Search

Results 1 - 20 of 26,053  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: subject: Oncology remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
Material Type:
Article 		Add to My Research

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial

The lancet oncology, 2017-03, Vol.18 (3), p.357-370 [Peer Reviewed Journal]

The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license ;2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license ;Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Mar 01, 2017 ;2017. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license 2017 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(17)30043-8 ;PMID: 28163000 ;CODEN: LANCAO

Full text available

Citations Cited by
2
Development of an evidence‑based, theory‑driven, and culturally appropriate character strengths-based intervention for breast cancer patients, following the Medical Research Council Framework
Development of an evidence‑based, theory‑driven, and culturally appropriate character strengths-based intervention for breast cancer patients, following the Medical Research Council Framework
Material Type:
Article 		Add to My Research

Development of an evidence‑based, theory‑driven, and culturally appropriate character strengths-based intervention for breast cancer patients, following the Medical Research Council Framework

Supportive care in cancer, 2023-01, Vol.31 (1), p.45-45, Article 45 [Peer Reviewed Journal]

The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. ;ISSN: 0941-4355 ;EISSN: 1433-7339 ;DOI: 10.1007/s00520-022-07538-w ;PMID: 36525147

Full text available

Citations Cited by
3
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy
Material Type:
Article 		Add to My Research

Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy

Clinical cancer research, 2017-12, Vol.23 (24), p.7543-7549 [Peer Reviewed Journal]

2017 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Dec 15, 2017 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-16-3142 ;PMID: 28972045

Full text available

Citations Cited by
4
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center
Material Type:
Article 		Add to My Research

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center

Leukemia, 2015-02, Vol.29 (2), p.312-320 [Peer Reviewed Journal]

COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Feb 2015 ;Macmillan Publishers Limited 2015. ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/leu.2014.242 ;PMID: 25113226

Full text available

Citations Cited by
5
Abstracts of the 15th International VHL Medical/Research Symposium
Abstracts of the 15th International VHL Medical/Research Symposium
Material Type:
Article 		Add to My Research

Abstracts of the 15th International VHL Medical/Research Symposium

Endocrine pathology, 2022-12, Vol.33 (4), p.528-533 [Peer Reviewed Journal]

Springer Science+Business Media, LLC, part of Springer Nature 2022 ;Springer Science+Business Media, LLC, part of Springer Nature 2022. ;ISSN: 1046-3976 ;EISSN: 1559-0097 ;DOI: 10.1007/s12022-022-09738-w ;PMID: 36414792

Full text available

Citations Cited by
6
Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center
Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center
Material Type:
Article 		Add to My Research

Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center

International journal of clinical oncology, 2021-10, Vol.26 (10), p.1793-1804 [Peer Reviewed Journal]

Japan Society of Clinical Oncology 2021 ;Japan Society of Clinical Oncology 2021. ;ISSN: 1341-9625 ;EISSN: 1437-7772 ;DOI: 10.1007/s10147-021-01963-3

Full text available

Citations Cited by
7
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer
Material Type:
Article 		Add to My Research

Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

NPJ breast cancer, 2021-01, Vol.7 (1), p.1-1, Article 1 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2374-4677 ;EISSN: 2374-4677 ;DOI: 10.1038/s41523-020-00208-2 ;PMID: 33397968

Full text available

Citations Cited by
8
COVID-19: global consequences for oncology
COVID-19: global consequences for oncology
Material Type:
Article 		Add to My Research

COVID-19: global consequences for oncology

The Lancet Oncology, 2020-04, Vol.21 (4), p.467-467 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(20)30175-3 ;PMID: 32240603

Digital Resources/Online E-Resources

Citations Cited by
9
Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin’s Lymphoma (High Grade)
Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin’s Lymphoma (High Grade)
Material Type:
Article 		Add to My Research

Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin’s Lymphoma (High Grade)

Indian journal of medical and paediatric oncology, 2017-01, Vol.38 (1), p.51-58 [Peer Reviewed Journal]

Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.) ;COPYRIGHT 2017 Medknow Publications and Media Pvt. Ltd. ;Copyright Medknow Publications & Media Pvt. Ltd. Jan/Mar 2017 ;Copyright: © 2017 Indian Journal of Medical and Paediatric Oncology 2017 ;ISSN: 0971-5851 ;EISSN: 0975-2129 ;DOI: 10.4103/0971-5851.203500 ;PMID: 28469337

Full text available

Citations Cited by
10
Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential
Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential
Material Type:
Article 		Add to My Research

Guidance on the need for contraception related to use of pharmaceuticals: the Japan Agency for Medical Research and Development Study Group for providing information on the proper use of pharmaceuticals in patients with reproductive potential

International journal of clinical oncology, 2022-05, Vol.27 (5), p.829-839 [Peer Reviewed Journal]

The Author(s) 2022 ;2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1341-9625 ;EISSN: 1437-7772 ;DOI: 10.1007/s10147-022-02149-1 ;PMID: 35347493

Full text available

Citations Cited by
11
A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice
A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice
Material Type:
Article 		Add to My Research

A Randomised Controlled Trial of Consent Procedures for the Use of Residual Tissues for Medical Research: Preferences of and Implications for Patients, Research and Clinical Practice

PloS one, 2016-03, Vol.11 (3), p.e0152509-e0152509 [Peer Reviewed Journal]

COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Rebers et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Rebers et al 2016 Rebers et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0152509 ;PMID: 27028128

Full text available

Citations Cited by
12
Indian council of medical research consensus document for the management of pancreatic cancer
Indian council of medical research consensus document for the management of pancreatic cancer
Material Type:
Article 		Add to My Research

Indian council of medical research consensus document for the management of pancreatic cancer

Indian journal of medical and paediatric oncology, 2019-01, Vol.40 (1), p.9-14 [Peer Reviewed Journal]

Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). ;COPYRIGHT 2019 Medknow Publications and Media Pvt. Ltd. ;2019. This work is published under https://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0971-5851 ;EISSN: 0975-2129 ;DOI: 10.4103/ijmpo.ijmpo_29_19

Full text available

Citations Cited by
13
Stakeholders welcome proposal on the European Health Data Space
Stakeholders welcome proposal on the European Health Data Space
Material Type:
Article 		Add to My Research

Stakeholders welcome proposal on the European Health Data Space

The lancet oncology, 2022-12, Vol.23 (12), p.1492-1492 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(22)00691-X ;PMID: 36335972

Full text available

Citations Cited by
14
Opportunities and priorities for breast surgical research
Opportunities and priorities for breast surgical research
Material Type:
Article 		Add to My Research

Opportunities and priorities for breast surgical research

The lancet oncology, 2018-10, Vol.19 (10), p.e521-e533 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 2018 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30511-4 ;PMID: 30303126

Full text available

Citations Cited by
15
The importance of patient-reported outcomes in clinical trials and strategies for future optimization
The importance of patient-reported outcomes in clinical trials and strategies for future optimization
Material Type:
Article 		Add to My Research

The importance of patient-reported outcomes in clinical trials and strategies for future optimization

Patient related outcome measures, 2018-01, Vol.9, p.353-367 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 Mercieca-Bebber et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1179-271X ;EISSN: 1179-271X ;DOI: 10.2147/prom.s156279 ;PMID: 30464666

Full text available

Citations Cited by
16
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial
Material Type:
Article 		Add to My Research

Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial

The lancet oncology, 2021-07, Vol.22 (7), p.1023-1033 [Peer Reviewed Journal]

2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(21)00196-0

Full text available

Citations Cited by
17
Indian Council of Medical Research consensus document for the management of gall bladder cancer
Indian Council of Medical Research consensus document for the management of gall bladder cancer
Material Type:
Article 		Add to My Research

Indian Council of Medical Research consensus document for the management of gall bladder cancer

Indian journal of medical and paediatric oncology, 2015-04, Vol.36 (2), p.79-84 [Peer Reviewed Journal]

Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.) ;COPYRIGHT 2015 Indian Society of Medical and Paediatric Oncology ;COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd. ;Copyright Medknow Publications & Media Pvt Ltd Apr-Jun 2015 ;Copyright: © Indian Journal of Medical and Paediatric Oncology 2015 ;ISSN: 0971-5851 ;EISSN: 0975-2129 ;DOI: 10.4103/0971-5851.158829 ;PMID: 26157282

Full text available

Citations Cited by
18
Global post-mortem tissue donation programmes to accelerate cancer research
Global post-mortem tissue donation programmes to accelerate cancer research
Material Type:
Article 		Add to My Research

Global post-mortem tissue donation programmes to accelerate cancer research

Nature reviews. Cancer, 2024-05, Vol.24 (5), p.289-290 [Peer Reviewed Journal]

Springer Nature Limited 2024. ;ISSN: 1474-175X ;EISSN: 1474-1768 ;DOI: 10.1038/s41568-024-00683-w ;PMID: 38589555

Digital Resources/Online E-Resources

Citations Cited by
19
Raise standards for preclinical cancer research
Raise standards for preclinical cancer research
Material Type:
Article 		Add to My Research

Raise standards for preclinical cancer research

Nature (London), 2012-03, Vol.483 (7391), p.531-533 [Peer Reviewed Journal]

Copyright Nature Publishing Group Mar 29, 2012 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/483531a ;CODEN: NATUAS

Full text available

Citations Cited by
20
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
Material Type:
Article 		Add to My Research

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

The lancet oncology, 2018-10, Vol.19 (10), p.1385-1393 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 2018 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30380-2 ;PMID: 30196031

Full text available

Citations Cited by

Results 1 - 20 of 26,053  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1989  (13)
  2. 1989 To 1996  (29)
  3. 1997 To 2004  (312)
  4. 2005 To 2013  (1,542)
  5. After 2013  (24,168)
  6. More options open sub menu

Subject 

  1. Medical Research  (17,095)
  2. Science & Technology  (14,476)
  3. Life Sciences & Biomedicine  (13,240)
  4. Cancer Therapies  (10,461)
  5. Tumors  (10,278)
  6. Cancer  (9,807)
  7. Clinical Trials  (7,809)
  8. Humans  (7,441)
  9. Chemotherapy  (6,717)
  10. Metastasis  (6,714)
  11. Medical Prognosis  (5,537)
  12. Female  (4,377)
  13. Care And Treatment  (4,167)
  14. Breast Cancer  (4,113)
  15. Medicine, Experimental  (4,069)
  16. Immunotherapy  (3,966)
  17. Biotechnology Industry  (3,718)
  18. Male  (3,634)
  19. More options open sub menu

Language 

  1. English  (26,048)
  2. Japanese  (1,479)
  3. Turkish  (38)
  4. Norwegian  (35)
  5. Chinese  (7)
  6. Portuguese  (7)
  7. French  (5)
  8. German  (5)
  9. Russian  (3)
  10. Urdu  (3)
  11. Polish  (1)
  12. Afrikaans  (1)
  13. Spanish  (1)
  14. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait